European PRAC updated safety issues with Janssen COVID-19 Vaccine, EMA

PRAC has recommended including immune thrombocytopenia, dizziness and tinnitus as adverse reactions, and to re-classify ' thrombocytopenia ' , currently an important potential risk, as an important identified risk.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news